The biochips market is expected to reach USD 17.75 Billion by 2020 from USD 7.63 Billion in 2015, growing at a CAGR of 18.4% during the forecast period (2015–2020). Increasing adoption of personalized medicine, growing applications of biochips, and technological advancements are major drivers for biochips market.
Access Sample Report at www.reportsnreports.com/contacts/r….aspx?name=539530 .
Biochips market is segmented into DNA chips, lab-on-a-chip, protein chips, and other arrays. Based on applications, the DNA chips segment is categorized into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, agricultural biotechnology, drug discovery, and other applications (microbial genotyping, proteomics, toxicogenomics, screening and monitoring of patient data in clinical trials, and environmental biology).
Key Target Audience:
- Biochip manufacturers and distributors
- Pharmaceutical companies
- Biotechnology companies
- Research institutes
- Academic Institutes
- Contract research organizations
- Research and consulting companies
In report, biochips market is segmented on basis of type, application, fabrication technology, end user, & region.
Based on type, market is segmented into DNA chips, lab-on-a-chip, protein chips & other arrays. Based on applications, lab-on-a-chip segment is classified into genomics, proteomics, drug discovery, IVD & POC clinical diagnostics, & other applications (biodefense, food pathogen identification, and environmental contamination).
More Information at www.reportsnreports.com/contacts/i….aspx?name=539530 .
The biochips market is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users (blood banks, CROs, forensic labs, point-of-care settings, home health agencies, nursing homes, and local public health laboratories).Similarly, based on fabrication technology, the biochips market is segmented into microarrays and microfluidics.
2 Competitive Situation and Trends
3 Agreements, Partnerships, and Collaborations
5 Product Launches and Enhancements
7 Other Developments
Major players in biochips market include Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc.
(U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), and Thermo Fisher Scientific, Inc.
Access report at www.reportsnreports.com/contacts/d….aspx?name=539530 .
This research report focuses on various levels of analysis - industry analysis (industry trends) and company profiles, which together comprise & discuss basic views on competitive landscape; emerging and high-growth segments of biochips market; high-growth regions; & market drivers, restraints, & opportunities.
Increasing adoption of personalized medicine, growing applications of biochips, & technological advancements are major drivers for biochips market. However, unclear regulatory guidelines, high instrumentation costs, & absolute quantification of specific mRNA may restrain market growth to a certain extent.
For more information:Make an Inquiry about this report HERE!